Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Myeloid × 1 year × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 320 Leukemia, Myeloid, Acute 269 Myeloproliferative Disorders 136 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 127 Precursor Cell Lymphoblastic Leukemia-Lymphoma 107 Primary Myelofibrosis 88 Leukemia, Myelomonocytic, Chronic 88 Leukemia 69 Lymphoma, Non-Hodgkin 63 Polycythemia Vera 58 Hodgkin Disease 46 Multiple Myeloma 45 Hematologic Neoplasms 44 Lymphoma 39 Leukemia, Lymphocytic, Chronic, B-Cell 38 Leukemia, Biphenotypic, Acute 38 Thrombocythemia, Essential 36 Myelodysplastic-Myeloproliferative Diseases 28 Leukemia, Myeloid, Chronic-Phase 26 Anemia, Refractory, with Excess of Blasts 24 Neoplasms 22 Hematologic Diseases 22 Lymphoma, Follicular 21 Lymphoma, Mantle-Cell 20 Anemia, Aplastic 20 Burkitt Lymphoma 19 Blast Crisis 19 Lymphoma, B-Cell, Marginal Zone 17 Recurrence 16 Leukemia, Myeloid 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡